Advertisement
Screener

OCULAR THERAPEUTIX, INC (OCUL) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

OCULAR THERAPEUTIX, INC Cash Flow Breakdown

Cash flow breakdown shows where OCULAR THERAPEUTIX, INC's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $204.88M went out.
  • Fiscal year ended 2025-12-31: from investing, $11.88M went out.
  • Fiscal year ended 2025-12-31: from financing, $561.72M came in.
  • Fiscal year ended 2025-12-31: change in cash, $344.96M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$204.88M-$11.88M$20.54M$541.18M*$344.96M
2024-12-31-$134.68M-$1.29M$14.74M$317.37M*$196.15M
2023-12-31-$70.23M-$6.09M-$26.13M$82.47M$117.26M-$3.78M*$93.51M
2022-12-31-$59.60M-$3.71M$514.00K$940.00K*-$61.86M
2021-12-31-$65.55M-$1.19M$2.59M-$63.89M
2020-12-31-$53.55M-$841.00K$224.68M$3.33M*$173.62M
2019-12-31-$77.58M-$2.24M$37.54M$37.80M*-$4.47M
2018-12-31-$49.23M-$1.89M$61.57M$7.07M*$17.52M
2017-12-31-$50.47M$26.95M$29.24M$2.77M*$8.49M
2016-12-31-$34.00M$37.07M$627.00K$3.65M
2015-12-31-$33.74M-$38.57M$65.61M-$6.61M
2014-12-31-$20.50M-$38.59M$69.52M$9.45M*$19.89M
2013-12-31-$12.64M-$387.00K$7.00K$6.68M*-$6.35M
2012-12-31-$12.59M$3.81M$3.00K$27.29M*$18.52M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30-$67.27M*-$3.37M*$1.68M*$902.00K*
2026-03-31-$65.99M-$4.66M$294.00K-$70.36M
2025-12-31-$54.25M*-$2.84M*$2.94M*$446.44M*
2025-09-30-$50.73M*-$5.99M*$10.36M*
2025-06-30-$55.24M*-$1.11M*$3.07M*$94.74M*
2025-03-31-$44.67M-$1.93M$4.18M-$42.42M
2024-12-31-$39.43M*-$202.00K*$3.99M*$524.00K*
2024-09-30-$36.56M*-$89.00K*$4.18M*
2024-06-30-$24.80M*-$742.00K*$1.70M*
2024-03-31-$33.89M-$255.00K$316.35M$4.87M*$287.08M
2023-12-31-$22.45M*-$459.00K*$0.00*$107.73M*
2023-09-30-$7.73M*-$259.00K*$708.00K*$51.23M*
2023-06-30-$20.07M*-$1.99M*$403.00K*$9.24M*
2023-03-31-$19.97M-$3.38M$78.00K-$23.27M
2022-12-31-$16.96M*-$2.15M*$0.00*
2022-09-30-$13.17M*-$794.00K*$374.00K*
2022-06-30-$10.88M*-$495.00K*$11.00K*
2022-03-31-$18.60M-$276.00K$129.00K-$18.75M
2021-12-31-$15.15M*-$631.00K*$172.00K*
2021-09-30-$12.98M*-$276.00K*$679.00K*
2021-06-30-$20.06M*-$129.00K*$538.00K*$2.13M*
2021-03-31-$17.36M-$158.00K-$275.00K-$887.00K*-$18.68M
2020-12-31-$6.25M*-$253.00K*$161.97M*$1.94M*
2020-09-30-$13.66M*-$214.00K*-$318.00K*
2020-06-30-$14.80M*-$125.00K*$50.34M*$728.00K*
2020-03-31-$18.85M-$249.00K$12.69M-$6.29M
2019-12-31-$19.47M*-$601.00K*$8.89M*
2019-09-30-$19.54M*-$419.00K*$18.58M*
2019-06-30-$19.18M*-$493.00K*$5.11M*
2019-03-31-$19.39M-$725.00K$4.95M$37.35M*$22.19M
2018-12-31-$13.65M*-$479.00K*$5.61M*$10.72M*
2018-09-30-$10.87M*-$473.00K*$12.84M*-$1.47M*
2018-06-30-$12.23M*-$556.00K*$8.13M*-$1.42M*
2018-03-31-$12.47M-$381.00K$34.99M-$763.00K*$21.37M
2017-12-31-$10.38M*-$564.00K*$581.00K*$625.00K*-$9.63M*
2017-09-30-$14.38M*$969.00K*$1.58M*-$11.88M*
2017-06-30-$11.13M*$18.70M*$800.00K*$8.37M*
2017-03-31-$14.58M$7.85M$26.27M$2.21M*$21.75M
2016-12-31-$7.61M*-$10.88M*$46.00K*$647.00K*-$19.30M*
2016-09-30-$7.33M*$11.32M*$78.00K*$4.06M*
2016-06-30-$9.80M*$11.76M*$70.00K*$1.96M*
2016-03-31-$9.26M$24.87M$5.00K$15.43M
2015-12-31-$8.64M*-$2.09M*$0.00*-$10.41M*
2015-09-30-$9.70M*-$27.59M*-$34.00K*-$37.49M*
2015-06-30-$8.53M*$8.96M*$110.00K*$65.62M*$66.16M*
2015-03-31-$6.88M-$17.85M$34.00K-$24.87M
2014-12-31-$5.63M*-$37.77M*$0.00*-$43.50M*
2014-09-30-$6.33M*-$274.00K*$4.00K*$67.55M*$60.95M*
2014-06-30-$4.51M*-$248.00K*$3.00K*$11.95M*$7.19M*
2014-03-31-$4.03M-$297.00K$21.00K-$4.75M
2013-12-31-$3.46M*-$206.00K*$5.00K*-$4.11M*
2013-09-30-$2.85M*-$109.00K*$0.00*-$3.41M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Zai Lab Ltd (ZLAB)$2.241B-113.34
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05